Biomatter lands $18M to speed up enzyme development with AI
Biomatter, a company specialising in customenzyme design, has raised $18 million in an oversubscribed Series A fundinground led by Astanor, with participation from existing investors UVC Partners,Inve...
Tech.eu2 min read